Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans.
By Tommi Vatanen, A. Kostic, Eva d’Hennezel, Heli Siljander, Eric A. Franzosa, Moran Yassour, Raivo Kolde, H. Vlamakis, Timothy D. Arthur, A. Hämäläinen and 15 more. Cell, 2016
752 citations recorded by the source corpus.
Subfields: Genetics, Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/f7fdf118086c158a5a2eb0e3c384a16a32b227cc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Molecular Biology
- Eric A. Franzosa
- Curtis Huttenhower
- Ramnik J. Xavier
- Chengwei Luo
- Tim D. Spector
- Leon O. Murphy
- Henry J. Haiser
- Zigui Chen
Citations in the corpus
- Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation. (2017, background): “…including inflammatory bowel disease (IBD) (Gevers et al., 2014), intestinal cancers (Kostic et al., 2013), obesity (Turnbaugh et al., 2009), diabetes (Kostic et al., 2015; Vatanen et al., 2016), Parkinson’s disease (Samp- Ce son et al., 2016), and rheumatoid arthritis (Zhang et al., 2015).”
- Stunted microbiota and opportunistic pathogen colonisation in caesarean section birth (2019, neutral): “…metagenomic studies of large, longitudinal cohorts are required to establish the impact and risks of early life events on the gut microbiota assembly, particularly during the neonatal period where pioneering microbes could influence subsequent microbiota and immune system development 16,17 .”
- Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration (2019, background): “For example, a heightened quantity of lipopolysaccharide (LPS) producing subtypes during this time can increase immune activation and possibly mediate autoimmune diseases in later life, acknowledged to be on the rise in the western world [14].”
- Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization (2020, background): “dorei has been reported to suppress colonic ACE2 expression(21) and to calibrate host immune response.(39,40) The highest SARS-CoV-2 mortality and morbidity have been reported in older patients and in those with underlying chronic diseases that are associated with inflammation, such as hypertension,”